Mallinckrodt Announces 2021 Advancing Extracorporeal Photopheresis Immunomodulation Investigator Award

-- Rich diversity of cutting-edge ECP science represented in Mallinckrodt's 2021 research award -- DUBLIN, March 19, 2021 /PRNewswire/ -- A project that will analyze the immunomodulatory effects of extracorporeal photopheresis therapy (ECP) through...
Canali: Ricerca Medica

Autore dell'articolo: Staff